The indications for which paroxetine is currently approved in EU includemajor depressive disorder (MDD), panic disorder, obsessive compulsive disorder (OCD), social phobia/ social anxiety disorder (SAD), generalised anxiety disorder (GAD) and post-traumatic stress disorder (PTSD).